arsenic trioxide has been researched along with Cancer of the Thyroid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Autilio, TM; Besharat, ZM; Catanzaro, G; Citarella, A; Durante, C; Elisei, R; Ferretti, E; Pecce, V; Po, A; Rughetti, A; Spinello, Z; Trocchianesi, S; Verrienti, A | 1 |
| Au, WY; Fong, BM; Lang, BH; Mao, KJ; Tam, S | 1 |
| Firkin, F | 1 |
| Brossart, P; Czarnocka, B; Fröhlich, E; Wahl, R | 1 |
| Brossart, P; Fröhlich, E; Wahl, R | 1 |
5 other study(ies) available for arsenic trioxide and Cancer of the Thyroid
| Article | Year |
|---|---|
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance.
Topics: Arsenic Trioxide; Humans; Signal Transduction; Thyroid Neoplasms; Tyrosine Kinase Inhibitors; Zinc Finger Protein GLI1 | 2023 |
Thyroid arsenic content and papillary thyroid carcinoma arising 10 years after oral arsenic trioxide therapy for refractory acute promyelocytic leukemia.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma; Carcinoma, Papillary; Female; Humans; Leukemia, Promyelocytic, Acute; Neoplasms, Second Primary; Oxides; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Young Adult | 2014 |
Carcinogenic risk of retained arsenic after successful treatment of acute promyelocytic leukemia with arsenic trioxide: a cause for concern?
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma; Carcinoma, Papillary; Female; Humans; Leukemia, Promyelocytic, Acute; Neoplasms, Second Primary; Oxides; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2014 |
Antitumor effects of arsenic trioxide in transformed human thyroid cells.
Topics: Adenocarcinoma, Follicular; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Biological Transport, Active; Carcinoma, Papillary; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Glucose; Glutathione; Humans; Iodides; Iodine Radioisotopes; Oncogene Protein v-akt; Oxides; Phosphatidylinositol 3-Kinases; Radiation Tolerance; Reactive Oxygen Species; Thyroid Neoplasms | 2008 |
Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Carcinoma; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Iodides; Lovastatin; Neoplasm Metastasis; Oxides; Pyrazines; Sirolimus; Thymus Gland; Thyroid Neoplasms; Tretinoin | 2009 |